Riggs Josh
SEC insider (Form 3/4/5 filer). CIK 0001956391. CEO and President at Insight Molecular Diagnostics Inc. (IMDX). 4 reported Form 4/5 transactions since Sep 2024; latest on Mar 26, 2026. Located in NASHVILLE, TN.
Companies Riggs Josh has filed insider reports for
- Insight Molecular Diagnostics Inc. (IMDX): Director, Officer, CEO and President
Riggs Josh
CIK: 0001956391
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Insight Molecular Diagnostics Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Mar 26, 2026IMDX
Insight Molecular Diagnostics Inc.
ExerciseDirect47.2K shares- - Mar 26, 2026IMDX
Insight Molecular Diagnostics Inc.
Tax PaymentDirect12.3K shares at avg. $4.11$51K - Sep 28, 2025IMDX
Insight Molecular Diagnostics Inc.
AwardDirectOption to Purchase Common Stock
400K shares- - Mar 26, 2025OCX
Oncocyte Corp
AwardDirectRestricted Stock Units
188.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 26, 2026 | IMDX Insight Molecular Diagnostics Inc. | Exercise | 47,170 | - | $0 | Direct |
| Mar 26, 2026 | IMDX Insight Molecular Diagnostics Inc. | Tax Payment | 12,310 | $4.11 | $50,594 | Direct |
| Sep 28, 2025 | IMDX Insight Molecular Diagnostics Inc. | Award Option to Purchase Common Stock | 400,000 | - | - | Direct |
| Mar 26, 2025 |  OCX Oncocyte Corp | Award Restricted Stock Units | 188,679 | - | - | Direct |
1-4 of 4 transactions